(svy didn't make the time cut-off - looks good)
only some of todays anns, incls free typos, imo's, etc's, as well as a common sense waiver to read the originals:
starts trading
- pgg (11am)
change dir interest
- scl (acquire), elo (acquire), vg1 (acquire), web (acquire), tgf x 2 (acquire),
change subs holding
- wgn (increase), pea (decrease), dti (increase), hco (decrease, consol), ori (decrease), asl (increase), elo (increase), lsh (increase), a2m (increase)
ceasing subs holder
- a2m, nuf,
becoming subs holder
- siq,
trading halts
- iap (material acquisition), icg (cr), eve (cr), lio (farm-out update), dev (cr), nwc (cr),
hwk - maiden ind/inf jorc resource big sandy li project (usa), 32.5mt @ 0.185% li (0.39% li2o equiv) for 60,300t li (320,800t li carbonate (li2co3) equiv)
rdn - identifies 3rd prospect at kalabak cu-au project (bulgaria up to 75%)
hot - 1 for 2 pro rata non renounc at 0.13
mct - extensin to entitlement offer from 02/10 to 16/10
enr/ncm - first phase rc drilling commences at hutch find prospect (wa), up to 17 holes, assays expected nov
mmm - approx $8m funding from us and wow in form of commercial loan facility and snr secured commercial loan
apc - pre-conc pond trials at lake wells sop project, with accpetable levels of brine seepage (approx 2%)
zmi - relatively narrow, hi grade zn, good grade pb, (with very narrow higher grade zn, pb) deep results, 20m @ 6.9% zn, 1.0% pb from 285m (2m @ 17.6% zn, 5.5% pb from 400m)
imm - recruitment of further patients in phase 2 trial (non small cell lung cancer) due to safety and efficacy levels exceeding baseline in initial patients
jms - q2 report
s2r - very narow, hi grade, shallow/relatively shallow au results, 1m @ 36.2g/t au from 41.9m, 0.6m @ 30.7g/t au from 76m, 0.5m @ 16.5g/t au from 83m, 1m @ 7.6g/t au from 50m, plus narrow lower grade au results
gal - 3,500-4,000m aircore drilling commnces at lantern ni prospect (wa), assays early nov
arn - ground mag survey completed at penny sth au project (wa)
dhr - visible au, ag in rock chip samples
rap - ce mark approval for latest version of smartphone respiratory diagnostic test extnds to adult testing of some diseases, now able to be sold in eu
mmj - invest c$6m in weedmd inc (canadian co)
ttm - historical rock chip and channel samples at corriocco au project peru, up to 57.2g/t au
slc - firm commitments for inst placement and ent offer of $72m at $0.82
ash - seeking to rebnegotiate acquisition deal due to dd
iap - acquires 3 commercial prpoerties for $81m, with inst placement of $84m to fund at $1.52
ckf - refinancing exisitngf syndicated debt facilities
apt - price query, no, media story
fxl - adds high profile retailers to its buy now pay later platform humm
var - signs conditional agreemtn to acquire option over novales udias zn project in spain
kta - agreement ot acquire beklgravia cu-au project (nsw)
toe - underwritten spp to raise $3.5m based on 5day vwap before issue
ged - placement to sophis at $0.026 to raise $1.055m
bxb - enrollment of patients completed for phase 2 diabetic kidney disease study
spl - usfda authorises use of azd0466 (blood cancers) in clincial trials under investigational new drug application
- Forums
- ASX - Day Trading
- Morning trading September 26
Morning trading September 26, page-2
-
- There are more pages in this discussion • 255 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)